Testosterone gels for FTM trans men: what the data says
Quick answer
Testosterone gel (e.g., AndroGel 1.62%, Testim) delivers testosterone transdermally with absorption that varies significantly by individual, producing serum levels that frequently fall below the male reference range in trans masculine patients. Inadequate serum levels are associated with poor virilization outcomes, and monitoring requires correctly timed labs drawn during peak absorption windows. Patients experiencing subtherapeutic response should have their delivery method and dosing evaluated by a clinician experienced in gender-affirming hormone therapy, not adjusted based on community protocols.
Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team· This is not a transcript. It is our independent review of the video above.
What's this video probably claiming?
Based on the caption "gels not doing it for me sadly" and the FTM trans community hashtags, this creator is almost certainly sharing frustration that testosterone gel is not producing the masculinizing results they expected. This is one of the most common complaints you'll see across FTM TikTok: inadequate virilization, slow beard growth, minimal voice changes, or persistently high estrogen levels despite using a transdermal testosterone product. The creator may be comparing gels unfavorably to injections, which tend to dominate community preference in trans masculine spaces. This video likely reflects a real clinical phenomenon rather than misinformation, but the framing and conclusions the creator draws matter a lot. Without the transcript, we're analyzing the topic rather than specific claims, but the pattern here is well-documented and worth unpacking carefully.
What does the science actually show?
Transdermal testosterone gels have consistently lower bioavailability and higher interindividual variability than intramuscular injections. A 2021 study by Cocchetti et al. in the Journal of Clinical Medicine found that trans masculine individuals using transdermal testosterone had significantly lower serum testosterone levels compared to those on injectable testosterone enanthate, with a notable proportion failing to reach the male reference range of 300-1000 ng/dL. A separate review by Deutsch et al. (2015, LGBT Health) noted that gel absorption can vary by 30-50% depending on application site, skin hydration, body fat distribution, and individual metabolic factors. These are not minor variables. For someone with higher body fat percentages, transdermal uptake can be especially poor. The clinical picture is clear: gels work for some people and fail quietly for others, often without the prescribing clinician catching it because follow-up lab timing is inconsistent.
Where does the social media noise diverge from clinical reality?
The FTM TikTok community has largely concluded that injections are categorically superior to gels, and while that conclusion has some basis in pharmacokinetics, the framing often skips important nuance. Community advice frequently includes specific dosing suggestions, application hacks, or switching protocols that are presented as obvious fixes, but none of those should be self-directed. Transfer contamination is also underreported in community discourse: a 2010 FDA warning and subsequent studies (de Ronde, 2009, Clinical Endocrinology) documented testosterone exposure in children and female partners through skin contact with gel users. This risk is real and rarely mentioned in "gels suck, switch to shots" content. The community also conflates slow results with gel failure when the actual issue is often undertesting, meaning labs drawn at the wrong interval or not drawn at all. Social media consensus is not a substitute for monitored bloodwork.
What should you actually know?
If you're using testosterone gel and not seeing expected results, the first step is getting serum testosterone measured at the right time, typically 2-6 hours post-application for gels, not 24 hours later when levels have dropped. That single lab timing error causes more misdiagnosis of "gel failure" than actual absorption problems. If levels are genuinely subtherapeutic after correct measurement, switching delivery methods is a legitimate clinical conversation, not a self-directed decision. Injectable testosterone cypionate and enanthate do produce more stable and typically higher serum levels, but they also carry their own variables including injection site reactions and peak-trough fluctuations. Pellet therapy exists as another option but evidence in trans masculine populations specifically is limited. The right delivery method depends on your labs, your lifestyle, and your clinical picture. A TikTok comment section cannot determine that for you.
Video review standard
Clinical fact-check snapshot
FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.
Evidence signal
Source-backed review
Regulatory reality
Access rules depend on the compound and patient situation
Safety screen
Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.
This page currently connects to 7 source-backed evidence items through visible references or structured citation data.
PubMed evidence trail
Research sources used to frame this page
For Testosterone gels for FTM trans men: what the data says, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.
Cardiovascular Safety of Testosterone-Replacement Therapy
TRAVERSE trial anchor for cardiovascular-safety discussions in appropriately diagnosed men.
PubMed
Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline
Guideline anchor for diagnosis, monitoring, contraindications, and appropriate TRT framing.
PubMed
The human peptide GHK-Cu in prevention of oxidative stress and degenerative conditions of aging
Anchor review for copper peptide gene-expression and tissue-repair claims.
PubMed
Effects of glycyl-histidyl-lysine-Cu on wound healing
Search-backed PubMed trail for wound-healing claims where specific topical versus injectable context matters.
PubMed
Provider decision path
Use local research to choose a safer review path
Direct answer
Testosterone gels for FTM trans men: what the data says is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.
Evidence check
Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.
Safety check
Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.
Next step
Compare providers, services and access requirements in the directory before contacting a suitable care team.
Claim path
Keep researching this testosterone and trt video claims cluster
Best for searchers turning TRT social claims into a safer lab-backed provider discussion.
Claim verdict
The useful answer behind this video
Claim being checked
Testosterone gel (e.
FormBlends verdict
Testosterone gel (e.g., AndroGel 1.62%, Testim) delivers testosterone transdermally with absorption that varies significantly by individual, producing serum levels that frequently fall below the male reference range in trans masculine patients. Inadequate serum levels are associated with poor virilization outcomes, and monitoring requires correctly timed labs drawn during peak absorption windows. Patients experiencing subtherapeutic response should have their delivery method and dosing evaluated by a clinician experienced in gender-affirming hormone therapy, not adjusted based on community protocols.
Patient-safe next step
Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.
What to do with this video
Use the clip as a claim to verify, not a treatment plan
What it helps with
- Testosterone gel (e.g., AndroGel 1.62%, Testim) delivers testosterone transdermally with absorption that varies significantly by individual, producing serum levels that frequently fall below the male reference range in trans masculine patients. Inadequate serum levels are associated with poor virilization outcomes, and monitoring requires correctly timed labs drawn during peak absorption windows. Patients experiencing subtherapeutic response should have their delivery method and dosing evaluated by a clinician experienced in gender-affirming hormone therapy, not adjusted based on community protocols.
- Testosterone gels produce serum levels 30-50% lower on average than injectable testosterone in many individuals, with high interindividual variability in absorption.
- Lab timing matters: serum testosterone drawn more than 6 hours after gel application will underestimate true peak levels and may falsely suggest treatment failure.
What it may miss
- It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
- Compound access, legal status, and product quality still need a separate safety check.
- Social video captions rarely show the full evidence base behind a claim.
Best next step
Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.
Start provider reviewWhat You'll Learn
- Testosterone gels produce serum levels 30-50% lower on average than injectable testosterone in many individuals, with high interindividual variability in absorption.
- Lab timing matters: serum testosterone drawn more than 6 hours after gel application will underestimate true peak levels and may falsely suggest treatment failure.
- The FDA and multiple case reports have documented testosterone transfer to children and partners through skin contact with gel users, a risk rarely discussed in online trans communities.
- The Endocrine Society's 2017 guidelines specify that delivery method changes in gender-affirming hormone therapy require clinical evaluation, not self-directed switching.
- Injectable testosterone cypionate and enanthate produce more stable serum levels than gels for most patients, but peak-trough fluctuations with injections carry their own clinical considerations.
- Subtherapeutic gel response should be confirmed with correctly timed bloodwork before assuming the delivery method itself is the problem.
- Pellet therapy exists as an alternative but lacks robust evidence specifically in trans masculine populations, making it a lower-evidence option compared to gels and injections.
Interested in GLP-1 or peptide therapy?
Get matched with licensed-provider review to help decide if it is right for you.
About the Creator
Mesa · TikTok creator
206.8K views on this video
gels not doing it for me sadly #trans #ftm #transman
Sources & references
Citations extracted from our medical team's review. Click any citation to search PubMed.
Not medical advice. This video was made by Mesa, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.